🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of IVIG in...
Status
Unknown
Location
Ella Institute, Oncology institute, Sheba Medical Center
Start Date
2005-07
Trial ID
NCT00294476
Treatments Being Tested
Most of patients with autoimmune encephalitis are left with permanent cogni...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-04-07
Trial ID
NCT03530462
Treatments Being Tested
As of 30/03/2020, 715600 people have been infected with COVID-19 worldwide ...
Status
Completed
Location
CHU Sud Amiens
Start Date
2020-04-11
Trial ID
NCT04350580
Treatments Being Tested
A randomized, open-label, prospective, multicenter study designed to invest...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2019-02-28
Trial ID
NCT03684018
Treatments Being Tested
The goal of this clinical trial is to learn if mini-pool intravenous immuno...
Status
Recruiting
Location
Children's hospital - Assiut University
Start Date
2025-01-01
Trial ID
NCT07068126
Treatments Being Tested
To evaluate whether hepatitis B immune globulin with a high level of antibo...
Status
Completed
Location
Multiple Locations
Start Date
1975-11
Trial ID
NCT00000580
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
The goal of this study is to evaluate the safety and feasibility of IVIg ad...
Status
Active Not Recruiting
Location
Sunnybrook Health Sciences Centre
Start Date
2025-04-15
Trial ID
NCT07193953
ALT-101 is a first-in-human Phase 1 clinical trial testing a new antibody d...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2026-06-01
Trial ID
NCT07586618
Treatments Being Tested